Explaining the shift in US and European approaches to risk regulation.
Despite their prevalence, regulatory performance standards and their efficacy have been understudied.
Allegations in complaints befit a conspiracy novel – one that Apple argues is completely fictional.
Empirical evidence suggests that expert agencies perform no better than courts.
Challenges to branded drugs from generic firms have benefits and costs.
Empirical research reveals stronger benefit-cost analysis during less political rulemakings.
Solicitor General limits his Supreme Court arguments to the specifics of health insurance.
Obama and his Republican rivals seek different paths to energy independence.
Social welfare function incorporates distributional considerations into policy analysis.
Policy makers must consider how environmental regulation affects markets.
CBA methodology can respond to societal risk-aversion.
Republican presidential candidate says he would revoke “irrational” regulation.